- Home
- Media Center
- Press releases
- Research
Research
Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
Lilly and Merck are First to Join Janssen in this Pre-Competitive Initiative to Increase Efficiencies in Clinical Trials
Janssen Research & Development Submits Complete Response to the U.S. FDA on XARELTO® (rivaroxaban) for the Reduction of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome
Supplemental New Drug Application for XARELTO® to reduce the risk of stent thrombosis in patients with acute coronary syndrome also resubmitted
Janssen Research & Development, LLC, Sponsors First of its Kind Research Initiative to Advance Multiple Sclerosis Science
$5.4 Million in Funding Part of Healthy Minds Initiative
Janssen Research & Development, LLC Opens JANSSEN LABS at San Diego
Novel Life Science Innovation Center To Spur Science By Supporting Early-Stage Life Science Industry